Catalyst Wire Dossier Catalyst Wire Dossier

HR19006

· Fujian Shengdi Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HR19006, covering 2023-10-10 to 2023-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition [Phase 3]

See pricing